PRECISIONheor’ Staff Feature: Suepattra May-Slater, PhD
In this edition of the newsletter, we profile Medical Anthropologist and Principal Scientist, Suepattra May-Slater -- from her work with the NIH and in Africa, to her twin girls.
Don’t Miss Our Upcoming Webinar: Evidence Challenges and Synthesis Solutions for Health Economic Modeling
Join us on Thursday, June 4th at 12:00 PM EST for this live webinar, and learn how to utilize innovative approaches and models to improve the credibility of cost-effective models for disease treatment! Moderated by Precision's Ross Maclean, Dr. Jeroen Jansen and Shannon Cope share their unique perspectives and solutions.
Our Latest Webinar: Demonstrating the Short- and Long-term Value of Gene and Cellular Therapies is On Demand!
Larry Blandford, EVP, Managing Partner for Precision, moderates a video panel discussion tackling the evergreen challenge of how to demonstrate the short- and long-term value of a therapy when clinical data are lacking. The panel includes a variety of stakeholder perspectives, from payers to IDNs to economists. With Precision’s Jeremy Schafer, Avi Mamidi, Rebecca Dean, and David Carr.
Have You Visited Our New Website?
PRECISIONheor.com offers the same innovative approaches to addressing difficult questions as we have in the past, now with a fully-integrated offering of HEOR services that include evidence strategy, evidence synthesis, modeling and microsimulation, and real-world data research. Come take a look today!
PRECISIONheor’s Recent Thought Leadership
Our recent collection of thought leadership features scientific publications from Precision authors Joanna MacEwan, Jacki Chou, Shannon Cope, and others!
Download the New White Paper: Delivering on the Promise of Cell Therapy: Challenges and Trends
Get the new White Paper, Delivering on the Promise of Cell Therapy: Challenges and Trends, from Precision to explore the current landscape of cell therapy, with an emphasis on CAR-T products, highlighting the key challenges and opportunities sponsors face as they endeavor to translate these innovative treatments from the bench to the bedside.
Our Latest Webinar Now On Demand! Demonstrating the Short- and Long-term Value of Gene and Cellular Therapies
Larry Blandford, EVP, Managing Partner for Precision, moderates a video panel discussion tackling the evergreen challenge of how to demonstrate the short- and long-term value of a therapy when clinical data are lacking. The panel includes a variety of stakeholder perspectives, from payers to IDNs to economists. With Precision’s Jeremy Schafer, Avi Mamidi, Rebecca Dean, and David Carr.
Download the New White Paper: What Do Value Assessments Miss?
From Precision scientific advisor and Harvard professor Dr. Anupam Bapu Jena, this new White Paper presents a fresh approach on developing value assessment strategies, exploring how the definition of value can extend beyond quality, and cost of care.
Precision’s Shafrin in the Wall Street Journal: Drug Pricing and the Broader Quality of Life
Great recent thought leadership in the Wall Street Journal from Senior Director Jason Shafrin. In WSJ’s Opinion, he asks the question: Does ICER's pricing model threaten innovative health therapies?
HEOR in 2020: 4 Trends in Market Access Did You Miss Our Live Webinar Panel?
In this unique 1-hour video webinar cosponsored by HealthEconomics.com, Dr. Patti Peeples, HealthEconomics.com Founder and CEO, moderates a live panel discussion with Precision’s Dr. Peter Neumann, Dr. Anuam Jena, Dr. Jeroen Jansen, and Dr. Kathy Lang, discussing some of the year’s key trends and topics in HEOR, and what you need to know to be successful in 2020.